SK7332002A3 - Method of reducing tissue damage associated with ischemia - Google Patents

Method of reducing tissue damage associated with ischemia Download PDF

Info

Publication number
SK7332002A3
SK7332002A3 SK733-2002A SK7332002A SK7332002A3 SK 7332002 A3 SK7332002 A3 SK 7332002A3 SK 7332002 A SK7332002 A SK 7332002A SK 7332002 A3 SK7332002 A3 SK 7332002A3
Authority
SK
Slovakia
Prior art keywords
pyridazin
benzenesulfonyl
group
compound
carbon atoms
Prior art date
Application number
SK733-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Banavara L Mylari
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SK7332002A3 publication Critical patent/SK7332002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK733-2002A 2001-05-24 2002-05-24 Method of reducing tissue damage associated with ischemia SK7332002A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29339301P 2001-05-24 2001-05-24

Publications (1)

Publication Number Publication Date
SK7332002A3 true SK7332002A3 (en) 2003-05-02

Family

ID=23128899

Family Applications (1)

Application Number Title Priority Date Filing Date
SK733-2002A SK7332002A3 (en) 2001-05-24 2002-05-24 Method of reducing tissue damage associated with ischemia

Country Status (15)

Country Link
US (1) US6872722B2 (cs)
EP (1) EP1260224B1 (cs)
JP (1) JP2002370984A (cs)
KR (1) KR20020090321A (cs)
CN (1) CN1390547A (cs)
AT (1) ATE289510T1 (cs)
AU (1) AU761191B2 (cs)
CA (1) CA2387007A1 (cs)
CZ (1) CZ20021782A3 (cs)
DE (1) DE60203026T2 (cs)
ES (1) ES2236447T3 (cs)
HU (1) HUP0201738A3 (cs)
PL (1) PL354128A1 (cs)
SK (1) SK7332002A3 (cs)
ZA (1) ZA200203985B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240657T3 (es) * 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
WO2007069727A1 (ja) * 2005-12-16 2007-06-21 Sanwa Kagaku Kenkyusho Co., Ltd. 急性腎不全の予防または治療剤
EP1987829A4 (en) * 2006-02-20 2009-07-29 Sanwa Kagaku Kenkyusho Co PROPHYLACTIC OR THERAPEUTIC AGENT FOR LESIONS DUE TO BRAIN ISCHEMIA OR LESIONS DUE TO BRAIN ISCHEMIA WITH REPERFUSION IN BRAIN VASCULAR ACCIDENTS
US20240033263A1 (en) 2021-03-18 2024-02-01 Banavara MYLARI Combination of aldose reductase inhibitors and probenecid for the treatment of diabetic complications

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4939140A (en) 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH01258671A (ja) * 1987-12-01 1989-10-16 Morishita Pharmaceut Co Ltd 5−(1h−イミダゾール−1−イル)−3(2h)−ピリダジノン誘導体
US4996204A (en) 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
WO1992017446A2 (en) * 1991-03-28 1992-10-15 Pfizer Inc. Pyridazinone acetic acids aldose reductase inhibitors
US5834466A (en) 1994-12-22 1998-11-10 The Regents Of The University Of California Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
US5506228A (en) * 1995-02-23 1996-04-09 Merck & Co., Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
US5670504A (en) * 1995-02-23 1997-09-23 Merck & Co. Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
BR9813998A (pt) * 1997-11-19 2000-09-26 Kowa Co Novos derivados de piridazina e produtos medicinais contendo os mesmos como ingredientes efetivos
TWI241295B (en) * 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
JP2000247959A (ja) * 1999-02-26 2000-09-12 Kowa Co ピリダジン−3−オン誘導体及びこれを含有する医薬
ES2240657T3 (es) * 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
GEP20053675B (en) * 2001-03-30 2005-11-25 Pfizer Prod Inc Pyridazinone Aldose Reductase Inhibitors

Also Published As

Publication number Publication date
PL354128A1 (en) 2002-12-02
ZA200203985B (en) 2003-11-20
EP1260224A1 (en) 2002-11-27
CA2387007A1 (en) 2002-11-24
DE60203026D1 (de) 2005-03-31
DE60203026T2 (de) 2006-05-04
US20030008871A1 (en) 2003-01-09
KR20020090321A (ko) 2002-12-02
US6872722B2 (en) 2005-03-29
JP2002370984A (ja) 2002-12-24
CN1390547A (zh) 2003-01-15
HU0201738D0 (cs) 2002-07-29
HUP0201738A2 (hu) 2003-02-28
AU761191B2 (en) 2003-05-29
CZ20021782A3 (cs) 2003-03-12
ATE289510T1 (de) 2005-03-15
EP1260224B1 (en) 2005-02-23
HUP0201738A3 (en) 2003-11-28
AU4068502A (en) 2002-11-28
ES2236447T3 (es) 2005-07-16

Similar Documents

Publication Publication Date Title
RU2054004C1 (ru) Производные 3(2н)-пиридазинона или их фармацевтически приемлемые соли и фармацевтическая композиция на их основе
KR102304121B1 (ko) 심장 상태에 대한 피리미딘디온 화합물
JPWO1991016314A1 (ja) ピリダジノン誘導体
AU2005226359A1 (en) 9-substituted 8-oxoadenine compound
WO2020151605A1 (zh) 氘代苯甲氨嘧啶二酮衍生物及其用途
EP0751132B1 (en) Pyridazinone derivatives and processes for preparing the same
SK5782001A3 (en) Benzoylpyridazine derivative, process for the preparation thereof and pharmaceutical composition containing same
US5942511A (en) Allylthiopyridazine derivatives and process for preparing the same
US6730674B2 (en) Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors
AU761191B2 (en) Therapies for tissue damage resulting from ischemia
EP0661274A1 (en) Indane derivatives, processes for preparing the same and synthetic intermediate of the same
US8853248B2 (en) (1,2,3-triazolyl)sulfonyl derivatives
AU2002236131B2 (en) Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
US7582676B2 (en) 2-phenylpyran-4-one derivatives as selective COX-2 inhibitors
US5686452A (en) Indane derivative and processes for preparing the same
AU2002236131A1 (en) Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
JPH07224045A (ja) ピリダジノン誘導体,その製法及びその用途